FoxHollow Finds Rinspiration For Cardiac Market Entry Via Kerberos Purchase
This article was originally published in The Gray Sheet
Executive Summary
FoxHollow's acquisition of the Rinspiration thrombectomy device through its $32 mil. purchase of Kerberos Proximal Solutions provides the firm with immediate access to the coronary market
You may also be interested in...
Bayer Builds Cardiovascular Franchise With Possis Purchase
Bayer HealthCare will expand its cardiovascular device offerings by acquiring AngioJet thrombectomy system maker Possis Medical for $361 million under a deal announced Feb. 11
Bayer Builds Cardiovascular Franchise With Possis Purchase
Bayer HealthCare will expand its cardiovascular device offerings by acquiring AngioJet thrombectomy system maker Possis Medical for $361 million under a deal announced Feb. 11
FoxHollow Stock Up 25% In Q3 On SilverHawk Profitability, Merck Deal
FoxHollow's stock advanced 25.1% in the third quarter as investors took notice of the firm's first profitable quarter, increased adoption of the company's SilverHawk peripheral vessel plaque excision system and an expanded research agreement with Merck